Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life

Discussion: In real-life scenarios, concerns about CYP3A4 inhibition may outweigh compliance with recommendations. Large studies are needed to survey the risk:benefit of hematologist ’s decision to replace posaconazole with other antifungals.Chemotherapy
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research